Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Energous reports preliminary revenue of approximately $5.6 million for the year ended December 31, 2025, representing more than 630% year-over-year growth and record annual revenue.For the quarter...
-
IND filing of tivoxavir marboxil represents final step for formal consideration by the Center for the Biomedical Advanced Research and Development Authority (BARDA) for inclusion in strategic...
-
High Voltage Cables & Accessories Market Size, Share & Segmentation By Voltage Level, Conductor Type, Insulation Type, Application, End-Use | Forecast 2033
-
Austin, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Geriatric Care Devices Market Size & Growth Analysis: According to SNS Insider, The Geriatric Care Devices Market size valued at USD 14.80...
-
Semiconductor Testing Services Market Size, Share & By Package Technology, By Application, By Services, By End User, and Region | Global Forecast 2026-2033
-
Wegovy Pill vs Wegovy Shot: Daily oral vs weekly injectable semaglutide differences following 2026 FDA approval. Ro.co access pathway examined.
-
NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Lakeland Industries, Inc. (“Lakeland” or the “Company”) (NASDAQ:LAKE)...
-
Consumer report compares best hair regrowth formula 2026 options: BioGrow RX biotin supplements vs topical serums for daily routine fit.
-
Best TRT 2026: How men access at-home testosterone through Taurus Meds—costs, LabCorp testing, licensed providers, and online TRT explained.
-
Wegovy Pill by Ro: January 2026 consumer analysis examines oral GLP-1 legitimacy, Novo Nordisk integration, and no-insurance cash-pay options.